Bain Capital Life Sciences Investors, LLC Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$1.5T
Holdings
21
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (21 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HTFLHEARTFLOW INC | 12,448,158 | $419.0B | 27.81% | |
| 2 | NAMSNEWAMSTERDAM PHARMA COMPANY | 10,719,110 | $304.9B | 20.23% | |
| 3 | CDTXCIDARA THERAPEUTICS INC | 3,020,990 | $289.3B | 19.20% | |
| 4 | PHVSPHARVARIS N V | 3,181,275 | $79.4B | 5.27% | |
| 5 | OLMAOLEMA PHARMACEUTICALS INC | 6,843,954 | $67.0B | 4.45% | |
| 6 | YB4PSAVARA INC | 17,600,621 | $62.8B | 4.17% | |
| 7 | DNTHDIANTHUS THERAPEUTICS INC | 1,315,892 | $51.8B | 3.44% | |
| 8 | SLDBSOLID BIOSCIENCES INC | 7,911,669 | $48.8B | 3.24% | |
| 9 | UPBUPSTREAM BIO INC | 2,439,538 | $45.9B | 3.05% | |
| 10 | RPIDRAPID MICRO BIOSYSTEMS INC | 8,434,560 | $28.2B | 1.87% | |
| 11 | TNGXTANGO THERAPEUTICS INC | 2,712,008 | $22.8B | 1.51% | |
| 12 | CABACABALETTA BIO INC | 9,677,125 | $22.6B | 1.50% | |
| 13 | KYTXKYVERNA THERAPEUTICS INC | 3,368,370 | $20.2B | 1.34% | |
| 14 | ANNXANNEXON INC | 5,249,069 | $16.0B | 1.06% | |
| 15 | XFORX4 PHARMACEUTICALS INC | 2,436,588 | $8.3B | 0.55% | |
| 16 | AVIRATEA PHARMACEUTICALS INC | 2,485,638 | $7.2B | 0.48% | |
| 17 | XLOXILIO THERAPEUTICS INC | 4,566,817 | $3.8B | 0.26% | |
| 18 | MRSNMERSANA THERAPEUTICS INC | 346,545 | $2.7B | 0.18% | |
| 19 | CCCCC4 THERAPEUTICS INC | 1,111,910 | $2.5B | 0.16% | |
| 20 | IPSCCENTURY THERAPEUTICS INC | 3,538,609 | $1.8B | 0.12% | |
| 21 | NAMSNEWAMSTERDAM PHARMA COMPANY | 100,000 | $1.7B | 0.11% |